ArticleFrontiers in oncology2021

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers.

Hye Ryeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.